Yamada Tadataka 4
4 · Athira Pharma, Inc. · Filed Jun 1, 2021
Insider Transaction Report
Form 4
Yamada Tadataka
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-05-28+13,871→ 13,871 totalExercise: $19.94Exp: 2031-05-27→ Common Stock (13,871 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest on the earlier of (i) May 28, 2022, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after May 28, 2021.